IHE
iShares U.S. Pharmaceuticals ETF
1W: +1.8%
1M: +6.1%
3M: +4.9%
YTD: +25.6%
1Y: +44.6%
3Y: +90.9%
5Y: +85.2%
Error: Binder Error: Contents of view were altered: types don't match! Expected [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, VARCHAR], but found [VARCHAR, VARCHAR, VARCHAR, DOUBLE, DOUBLE, DOUBLE, BIGINT, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, DOUBLE, BIGINT, VARCHAR] instead
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
61.1
★★★★★
Altman Z-Score
8.39
Safe
Weight Coverage
99%
of portfolio analyzed
Holdings Matched
51
with fundamental data
InsiderStreet Scorecard
★★★★★
61.1
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
8.39
Safe Zone (>2.99)
Piotroski F-Score
6.1 / 9
Moderate
Beneish M-Score
-0.70
Possible Manipulator
Credit Score
—
Earnings Quality
63.0 / 100
Portfolio Valuation
P/E
44.24x
P/B
13.35x
P/S
9.48x
EV/EBITDA
27.23x
EV/Revenue
9.87x
P/FCF
43.95x
P/OCF
31.81x
PEG
1.93x
Earnings Yield
2.26%
FCF Yield
2.28%
OCF Yield
3.14%
Median P/E
-0.10x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+22.8%
Net Income
+14.7%
EPS
+16.0%
FCF
+38.1%
EBITDA
+26.6%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+20.8%
Rev CAGR 5Y
+12.4%
EPS CAGR 3Y
+22.9%
EPS CAGR 5Y
+15.2%
FCF CAGR 3Y
+6.6%
FCF CAGR 5Y
+11.3%
EBITDA CAGR 3Y
+23.8%
EBITDA CAGR 5Y
+13.5%
Payout Ratio
62.26%
Buyback Yield
1.34%
Dividend Yield
1.47%
Total Shareholder Return
2.13%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$106.61
Median 1Y
$119.57
5th Pctile
$86.30
95th Pctile
$165.70
Ann. Volatility
18.5%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 44.24 |
| Portfolio P/B | 13.35 |
| Portfolio P/S | 9.48 |
| EV/EBITDA | 27.23 |
| EV/Revenue | 9.87 |
| P/FCF | 43.95 |
| P/OCF | 31.81 |
| PEG | 1.93 |
| Earnings Yield | 2.26% |
| FCF Yield | 2.28% |
| OCF Yield | 3.14% |
| Median P/E | -0.10 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 69.79% |
| Operating Margin | 33.01% |
| Net Margin | 21.34% |
| FCF Margin | 21.55% |
| ROE | 32.48% |
| ROA | 11.65% |
| ROIC | 25.06% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.73 |
| Debt/Assets | 0.27 |
| Net Debt/EBITDA | 1.08 |
| Interest Coverage | 21.36 |
| Current Ratio | 1.24 |
| Quick Ratio | 0.91 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 22.76% |
| Net Income Growth | 14.74% |
| EPS Growth | 16.00% |
| FCF Growth | 38.15% |
| EBITDA Growth | 26.57% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 20.81% |
| Revenue CAGR 5Y | 12.41% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 22.95% |
| EPS CAGR 5Y | 15.24% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 6.60% |
| FCF CAGR 5Y | 11.28% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 23.78% |
| EBITDA CAGR 5Y | 13.49% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 21.23% |
| Net Income CAGR 5Y | 14.34% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 61.1 |
| IS Profitability | 65.9 |
| IS Balance Sheet | 56.6 |
| IS Earnings Quality | 63.0 |
| IS Growth | 54.6 |
| IS Value | 42.4 |
| IS Momentum | 73.0 |
| IS Safety | 83.4 |
| IS Quality | 72.1 |
| Altman Z-Score | 8.39 |
| Piotroski F-Score | 6.06 |
| Beneish M-Score | -0.70 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 1.47% |
| Payout Ratio | 62.26% |
| Buyback Yield | 1.34% |
| Total Shareholder Return | 2.13% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.612 |
| Earnings Stability | 0.340 |
| Earnings Persistence | 0.705 |
| Margin Stability | 0.940 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -0.10 |
| Median P/B | 2.73 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 98.87% |
| Holdings Matched | 51 |
| Total Holdings | 53 |